https://www.selleckchem.com/pr....oducts/zunsemetinib.
precision, sensitivity, and specificity reached 0.84, 0.88, 0.73, and 0.80, respectively. The proposed method has the potential to serve as a tool to screen for elderly people with cognitive impairment and predict high-risk cases of dementia at the asymptomatic stage, providing health care professionals with early signals that can prompt suggestions for a follow-up or a detailed diagnosis. The proposed method has the potential to serve as a tool to screen for elderly people with cognitive impairment and predict high-risk cases of d
Like
Comment
Share
